An Evaluation Of Verona Pharma Plc ADR (NASDAQ: VRNA) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

VRNA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Verona Pharma Plc ADR is $2.23B. A total of 0.84 million shares were traded on the day, compared to an average of 1.50M shares.

In the most recent transaction, ZACCARDELLI DAVID sold 398,400 shares of VRNA for 3.20 per share on Aug 13 ’24. After the transaction, the President and CEO now owns 15,850,704 company shares. In a previous transaction on Aug 12 ’24, ZACCARDELLI DAVID sold 1,600 shares at 3.13 per share. VRNA shares that President and CEO owns now total 16,249,104.

Among the insiders who sold shares, Hahn Mark W disposed of 398,400 shares on Aug 13 ’24 at a per-share price of $3.20. This resulted in the Chief Financial Officer holding 14,939,688 shares of VRNA after the transaction. In another insider transaction, Hahn Mark W sold 1,600 shares at $3.13 per share on Aug 12 ’24. Company shares held by the Chief Financial Officer now total 15,338,088.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VRNA has a high of $28.83 and a low of $11.39.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $2.08, while its Total Shareholder’s Equity was $148.00M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.

Most Popular

Related Posts